KalVista Pharmaceuticals (KALV) Return on Assets (2016 - 2024)
Historic Return on Assets for KalVista Pharmaceuticals (KALV) over the last 8 years, with Q4 2024 value amounting to 0.37%.
- KalVista Pharmaceuticals' Return on Assets changed N/A to 0.37% in Q4 2024 from the same period last year, while for Dec 2024 it was 0.37%, marking a year-over-year change of. This contributed to the annual value of 0.28% for FY2020, which is 400.0% down from last year.
- Per KalVista Pharmaceuticals' latest filing, its Return on Assets stood at 0.37% for Q4 2024.
- KalVista Pharmaceuticals' 5-year Return on Assets high stood at 0.12% for Q1 2021, and its period low was 0.63% during Q4 2024.
- In the last 3 years, KalVista Pharmaceuticals' Return on Assets had a median value of 0.38% in 2020 and averaged 0.37%.
- As far as peak fluctuations go, KalVista Pharmaceuticals' Return on Assets plummeted by -2200bps in 2020, and later soared by 2600bps in 2021.
- Over the past 3 years, KalVista Pharmaceuticals' Return on Assets (Quarter) stood at 0.26% in 2020, then soared by 54bps to 0.12% in 2021, then plummeted by -208bps to 0.37% in 2024.
- Its Return on Assets stands at 0.37% for Q4 2024, versus 0.63% for Q4 2024 and 0.52% for Q3 2024.